跳至主要内容
临床试验/NCT02612701
NCT02612701终止不适用

E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion

Cedars-Sinai Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
20
试验地点
2
主要终点
Myocardial Perfusion (change in capillary blood volume from baseline at 30 minutes)

研究概览

简要总结

E-cigarettes deliver nicotine by creating an aerosol of ultrafine particles. Many questions remain about the size and composition and especially about the potential toxicity of these particles. Thus, a key unanswered question-and the research question proposed-is whether e-cigarette aerosol triggers the same acute impairment in coronary microvessel function as does conventional cigarette smoke, which delivers a very well-defined exposure to fine particles and many fold greater exposure to toxic (combustion) products including volatile organic compounds (such as acrolein) that have been implicated in the pathogenesis of tobacco-related coronary disease.

Because the effects of nicotine on the human coronary microcirculation remain incompletely defined-with multiple potential vasodilator and vasoconstrictor actions each of which may vary by dose-we will determine the comparative effects of conventional cigarette smoke against e-cigarette aerosol with no nicotine, with low-dose nicotine, and with high-dose nicotine.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-49
  • Regular cigarette smoker defined as at least 1 pack year and ≥ 5/day
  • E-cigarette smoker defined as ≥ 1/week in the last 6 months.

排除标准

  • Sub-optimal echocardiography images as determined by the sonographer and/or investigators.
  • History of cardiopulmonary (including asthma or use of inhalers),
  • History of diabetes or dyslipidemia
  • History of psychiatric illness
  • Blood Pressure > 140/90
  • Body Mass Index ≤ 18.5 or ≥ 30 kg•m2
  • Evidence of any of the above by physical examination, Electrocardiogram (ECG) or echocardiogram
  • Resting Heart Rate > 100 beats/min
  • Cardiac rhythm disorder, specifically: rhythm other than sinus, Supraventricular Tachycardia (SVT), atrial fibrillation, ventricular tachycardia
  • Use of prescription medication except oral contraceptive pills
  • History of illicit drug use (self-stated)
  • Any other condition(s) deemed by the physician investigators that put subjects at risk for participating in the study

结局指标

主要结局

Myocardial Perfusion (change in capillary blood volume from baseline at 30 minutes)

时间窗: Baseline and 30 minutes after smoking

Myocardial contrast echocardiography will be used to measure regional myocardial perfusion - capillary blood volume

Myocardial Perfusion (change in microvascular flux rate from baseline at 30 minutes)

时间窗: Baseline and 30 minutes after smoking

Myocardial contrast echocardiography will be used to measure regional myocardial perfusion - microvascular flux rate

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Florian Rader

M.D, M.Sc.

Cedars-Sinai Medical Center

研究点 (2)

Loading locations...

相似试验